What Researchers Did
Researchers reviewed current scientific literature on the effects of hyperbaric oxygen treatment (HBOT) on mitochondrial function and oxidative stress.
What They Found
Hyperbaric oxygen treatment (HBOT) increases dissolved oxygen in the blood by 5- to 20-fold, significantly impacting mitochondrial function and the production of reactive oxygen species (ROS). While short-term HBOT can have deleterious effects on mitochondrial activity and ROS levels, long-term treatment improves mitochondrial function and decreases ROS by enhancing antioxidant defense mechanisms.
What This Means for Canadian Patients
Canadian patients with conditions linked to mitochondrial dysfunction or an imbalance in oxidative stress could potentially benefit from hyperbaric oxygen treatment. However, the specific therapeutic applications, optimal treatment protocols, and potential risks would require careful evaluation by healthcare professionals.
Canadian Relevance
There is no direct Canadian connection mentioned in this review article.
Study Limitations
As a review, this study synthesizes existing literature and does not present new experimental data or clinical trial results.